 Traditionally, infections were treated with imipenem or meropenem, but a steady rise in carbapenem-resistant "A. baumannii" has been noted.Consequently, treatment methods often fall back on polymyxins, particularly colistin.Colistin is considered a drug of last resort because it often causes kidney damage, among other side effects.